In a report released on March 10, Anupam Rama from J.P. Morgan maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report), with a price target of $44.00. The company’s shares closed ...
In a report released on March 6, Anupam Rama from J.P. Morgan maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report), with a price target of $45.00. The company’s shares closed ...
What should I know about this firm? J.P. Morgan Securities LLC advisors not only assist individuals with building their money by providing a variety of wealth management services, but also help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback